Michael Li, PhD, MPH

Core Affiliate, Combination Prevention Core


Michael Li, PhD, MPH, Assistant Professor in the UCLA Department of Family Medicine. They serve as a Project Director on multiple studies under Dr. Shoptaw while developing their own research on the role of stress biology in the links between social adversity, substance use, and HIV in sexual minorities of color. Dr. Li received a Bachelor degree in Biological Sciences from UC Irvine, a Master of Public Health from Cal State Fullerton, and a PhD in Preventive Medicine from the University of Southern California. They also served as a postdoctoral fellow at CBAM prior to being promoted to a faculty position.

Contact: mjli@mednet.ucla.edu

Featured Publications:

1. Reback, C. J., Landovitz, R. J., Benkeser, D., Jalali, A., Shoptaw, S., Li, M. J., Mata, R. P., Ryan, D., Jeng, P. J., & Murphy, S. M. (2024). Protocol for a randomized controlled trial with a stepped care approach, utilizing PrEP navigation with and without contingency management, for transgender women and sexual minority men with a substance use disorder: Assistance Services Knowledge-PrEP (A.S.K.-PrEP). Addiction science & clinical practice, 19(1), 79.


2. Li, M. J., Chau, B., Belin, T., Carmody, T., Jha, M. K., Marino, E. N., Trivedi, M., & Shoptaw, S. J. (2024). Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial. Addiction (Abingdon, England), 119(10), 1840–1845.


3. Li, M. J., Hassan, A., Javanbakht, M., Gorbach, P. M., & Shoptaw, S. J. (2024). Decision-making task performance and patterns of methamphetamine use in people assigned male at birth who have sex with men. Experimental and clinical psychopharmacology, 32(3), 350–357.

Last updated: 1/16/2025